エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/21 | 5,589 | 5,645 | 5,560 | 5,610 | +1 | ±0% | 896,800 |
2018/02/20 | 5,614 | 5,643 | 5,586 | 5,609 | -4 | -0.1% | 749,700 |
2018/02/19 | 5,592 | 5,626 | 5,564 | 5,613 | +38 | +0.7% | 1,095,100 |
2018/02/16 | 5,532 | 5,633 | 5,522 | 5,575 | +61 | +1.1% | 1,701,300 |
2018/02/15 | 5,468 | 5,588 | 5,402 | 5,514 | -241 | -4.2% | 2,757,200 |
2018/02/14 | 5,785 | 5,850 | 5,730 | 5,755 | -38 | -0.7% | 1,368,900 |
2018/02/13 | 5,912 | 5,971 | 5,772 | 5,793 | -119 | -2% | 1,312,800 |
2018/02/09 | 5,921 | 5,979 | 5,864 | 5,912 | -234 | -3.8% | 1,632,600 |
2018/02/08 | 6,066 | 6,172 | 6,066 | 6,146 | +51 | +0.8% | 1,020,300 |
2018/02/07 | 6,053 | 6,318 | 6,050 | 6,095 | +142 | +2.4% | 1,379,200 |
2018/02/06 | 6,122 | 6,167 | 5,837 | 5,953 | -369 | -5.8% | 1,948,100 |
2018/02/05 | 6,240 | 6,344 | 6,227 | 6,322 | +20 | +0.3% | 1,195,400 |
2018/02/02 | 6,334 | 6,347 | 6,261 | 6,302 | -61 | -1% | 664,200 |
2018/02/01 | 6,286 | 6,377 | 6,282 | 6,363 | +132 | +2.1% | 690,800 |
2018/01/31 | 6,269 | 6,300 | 6,226 | 6,231 | -59 | -0.9% | 841,700 |
2018/01/30 | 6,316 | 6,378 | 6,287 | 6,290 | -18 | -0.3% | 814,100 |
2018/01/29 | 6,345 | 6,405 | 6,302 | 6,308 | -37 | -0.6% | 582,800 |
2018/01/26 | 6,389 | 6,410 | 6,330 | 6,345 | -7 | -0.1% | 866,100 |
2018/01/25 | 6,369 | 6,403 | 6,347 | 6,352 | -45 | -0.7% | 619,900 |
2018/01/24 | 6,370 | 6,424 | 6,370 | 6,397 | -23 | -0.4% | 590,500 |
2018/01/23 | 6,333 | 6,447 | 6,319 | 6,420 | +83 | +1.3% | 689,800 |
2018/01/22 | 6,270 | 6,341 | 6,270 | 6,337 | +59 | +0.9% | 629,300 |
2018/01/19 | 6,349 | 6,359 | 6,251 | 6,278 | -25 | -0.4% | 1,098,500 |
2018/01/18 | 6,256 | 6,410 | 6,256 | 6,303 | -145 | -2.2% | 1,739,200 |
2018/01/17 | 6,421 | 6,458 | 6,369 | 6,448 | -25 | -0.4% | 1,001,500 |
2018/01/16 | 6,500 | 6,531 | 6,471 | 6,473 | -58 | -0.9% | 534,800 |
2018/01/15 | 6,521 | 6,559 | 6,465 | 6,531 | +10 | +0.2% | 792,200 |
2018/01/12 | 6,591 | 6,622 | 6,517 | 6,521 | -89 | -1.3% | 1,005,500 |
2018/01/11 | 6,630 | 6,660 | 6,582 | 6,610 | -42 | -0.6% | 729,000 |
2018/01/10 | 6,700 | 6,720 | 6,645 | 6,652 | -6 | -0.1% | 802,200 |
2018/01/09 | 6,620 | 6,708 | 6,615 | 6,658 | +86 | +1.3% | 1,014,700 |
2018/01/05 | 6,574 | 6,587 | 6,501 | 6,572 | -21 | -0.3% | 1,231,700 |
2018/01/04 | 6,497 | 6,599 | 6,464 | 6,593 | +177 | +2.8% | 1,455,800 |
2017/12/29 | 6,364 | 6,432 | 6,332 | 6,416 | +44 | +0.7% | 854,600 |
2017/12/28 | 6,349 | 6,519 | 6,345 | 6,372 | +49 | +0.8% | 1,257,800 |
2017/12/27 | 6,347 | 6,359 | 6,290 | 6,323 | +22 | +0.3% | 927,800 |
2017/12/26 | 6,179 | 6,354 | 6,161 | 6,301 | +153 | +2.5% | 2,168,200 |
2017/12/25 | 6,115 | 6,244 | 6,100 | 6,148 | +87 | +1.4% | 2,384,900 |
2017/12/22 | 6,406 | 6,407 | 5,970 | 6,061 | -1,057 | -14.8% | 7,516,700 |
2017/12/21 | 7,102 | 7,148 | 7,095 | 7,118 | -3 | ±0% | 713,800 |
2017/12/20 | 7,095 | 7,130 | 7,060 | 7,121 | +16 | +0.2% | 702,300 |
2017/12/19 | 7,045 | 7,108 | 7,025 | 7,105 | +72 | +1% | 868,400 |
2017/12/18 | 6,950 | 7,034 | 6,923 | 7,033 | +138 | +2% | 1,000,900 |
2017/12/15 | 6,877 | 6,909 | 6,829 | 6,895 | +53 | +0.8% | 924,200 |
2017/12/14 | 6,869 | 6,888 | 6,827 | 6,842 | -22 | -0.3% | 494,700 |
2017/12/13 | 6,850 | 6,895 | 6,821 | 6,864 | +149 | +2.2% | 887,100 |
2017/12/12 | 6,661 | 6,726 | 6,637 | 6,715 | +42 | +0.6% | 817,800 |
2017/12/11 | 6,574 | 6,674 | 6,540 | 6,673 | +140 | +2.1% | 834,200 |
2017/12/08 | 6,401 | 6,533 | 6,401 | 6,533 | +183 | +2.9% | 1,788,600 |
2017/12/07 | 6,310 | 6,385 | 6,305 | 6,350 | +45 | +0.7% | 703,100 |
1651~
1700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム